|
Valoración de DCF de Edwards Lifesciences Corporation (EW)
US | Healthcare | Medical - Devices | NYSE
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Edwards Lifesciences Corporation (EW) Bundle
¡Simplifique la valoración de Edwards Lifesciences Corporation (EW) con esta calculadora DCF personalizable! Con el Real Edwards Lifesciences Corporation (EW) Financials y las entradas de pronóstico ajustables, puede probar escenarios y descubrir el valor razonable de Edwards Lifesciences Corporation (EW) en minutos.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4,348.0 | 4,386.3 | 5,232.5 | 5,382.4 | 6,004.8 | 6,524.2 | 7,088.6 | 7,701.8 | 8,368.0 | 9,091.9 |
| Revenue Growth, % | 0 | 0.88086 | 19.29 | 2.86 | 11.56 | 8.65 | 8.65 | 8.65 | 8.65 | 8.65 |
| EBITDA | 1,308.4 | 1,074.3 | 1,890.1 | 1,960.4 | 1,767.6 | 2,042.9 | 2,219.7 | 2,411.7 | 2,620.3 | 2,846.9 |
| EBITDA, % | 30.09 | 24.49 | 36.12 | 36.42 | 29.44 | 31.31 | 31.31 | 31.31 | 31.31 | 31.31 |
| Depreciation | 114.6 | 135.4 | 163.3 | 166.8 | 144.9 | 187.3 | 203.5 | 221.1 | 240.3 | 261.0 |
| Depreciation, % | 2.64 | 3.09 | 3.12 | 3.1 | 2.41 | 2.87 | 2.87 | 2.87 | 2.87 | 2.87 |
| EBIT | 1,193.8 | 938.9 | 1,726.8 | 1,793.6 | 1,622.7 | 1,855.6 | 2,016.1 | 2,190.5 | 2,380.0 | 2,585.9 |
| EBIT, % | 27.46 | 21.41 | 33 | 33.32 | 27.02 | 28.44 | 28.44 | 28.44 | 28.44 | 28.44 |
| Total Cash | 1,516.9 | 1,402.6 | 1,466.8 | 1,215.3 | 1,644.5 | 1,890.2 | 2,053.7 | 2,231.4 | 2,424.4 | 2,634.1 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 599.1 | 602.8 | 664.9 | 699.1 | 836.9 | 876.3 | 952.1 | 1,034.4 | 1,123.9 | 1,221.1 |
| Account Receivables, % | 13.78 | 13.74 | 12.71 | 12.99 | 13.94 | 13.43 | 13.43 | 13.43 | 13.43 | 13.43 |
| Inventories | 640.9 | 802.3 | 726.7 | 875.5 | 1,168.2 | 1,078.3 | 1,171.6 | 1,272.9 | 1,383.1 | 1,502.7 |
| Inventories, % | 14.74 | 18.29 | 13.89 | 16.27 | 19.45 | 16.53 | 16.53 | 16.53 | 16.53 | 16.53 |
| Accounts Payable | 180.4 | 196.5 | 204.5 | 201.9 | 201.4 | 256.3 | 278.5 | 302.6 | 328.7 | 357.2 |
| Accounts Payable, % | 4.15 | 4.48 | 3.91 | 3.75 | 3.35 | 3.93 | 3.93 | 3.93 | 3.93 | 3.93 |
| Capital Expenditure | -278.4 | -407.3 | -329.8 | -264.8 | -266.3 | -409.0 | -444.4 | -482.8 | -524.6 | -570.0 |
| Capital Expenditure, % | -6.4 | -9.29 | -6.3 | -4.92 | -4.43 | -6.27 | -6.27 | -6.27 | -6.27 | -6.27 |
| Tax Rate, % | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 |
| EBITAT | 1,071.4 | 843.3 | 1,525.0 | 1,544.5 | 1,424.0 | 1,639.4 | 1,781.2 | 1,935.3 | 2,102.7 | 2,284.6 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -152.0 | 422.4 | 1,380.0 | 1,260.9 | 871.6 | 1,523.1 | 1,393.5 | 1,514.0 | 1,645.0 | 1,787.3 |
| WACC, % | 9.65 | 9.65 | 9.65 | 9.65 | 9.65 | 9.65 | 9.65 | 9.65 | 9.65 | 9.65 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 5,962.0 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 1,859 | |||||||||
| Terminal Value | 32,897 | |||||||||
| Present Terminal Value | 20,754 | |||||||||
| Enterprise Value | 26,716 | |||||||||
| Net Debt | -449 | |||||||||
| Equity Value | 27,165 | |||||||||
| Diluted Shares Outstanding, MM | 609 | |||||||||
| Equity Value Per Share | 44.58 |
What You Will Get
- Real EW Financials: Access to historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Dynamic Calculations: Intrinsic value and NPV are updated automatically.
- Scenario Analysis: Evaluate multiple scenarios to assess Edwards Lifesciences' future performance.
- User-Friendly Design: Designed for professionals while remaining approachable for newcomers.
Key Features
- 🔍 Real-Life EW Financials: Pre-filled historical and projected data for Edwards Lifesciences Corporation (EW).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Edwards Lifesciences’ intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Edwards Lifesciences’ valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Download: Get the pre-built Excel file featuring Edwards Lifesciences Corporation's (EW) financial data.
- Customize: Tailor your forecasts, including revenue growth, EBITDA %, and WACC.
- Update Automatically: Watch as the intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Develop various projections and instantly compare the results.
- Make Decisions: Leverage the valuation findings to inform your investment strategy.
Why Choose Edwards Lifesciences Corporation (EW)?
- Innovative Solutions: Leading the way in heart valve therapies and hemodynamic monitoring.
- Commitment to Quality: High standards in manufacturing ensure reliable medical devices.
- Patient-Centric Approach: Focused on improving patient outcomes through advanced technology.
- Global Reach: Operates in numerous countries, making a significant impact worldwide.
- Endorsed by Professionals: Trusted by healthcare providers for their expertise and reliability.
Who Should Use This Product?
- Investors: Accurately assess Edwards Lifesciences Corporation's (EW) fair value before making investment choices.
- CFOs: Utilize a professional-grade DCF model for financial reporting and analysis related to Edwards Lifesciences Corporation (EW).
- Consultants: Efficiently modify the template for valuation reports tailored to clients focused on Edwards Lifesciences Corporation (EW).
- Entrepreneurs: Acquire insights into financial modeling practices employed by leading healthcare companies, including Edwards Lifesciences Corporation (EW).
- Educators: Implement it as a teaching resource to illustrate valuation methodologies relevant to Edwards Lifesciences Corporation (EW).
What the Template Contains
- Pre-Filled DCF Model: Edwards Lifesciences Corporation’s (EW) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital specific to (EW).
- Financial Ratios: Evaluate (EW)’s profitability, leverage, and efficiency metrics.
- Editable Inputs: Modify assumptions such as growth, margins, and CAPEX to tailor your scenarios for (EW).
- Financial Statements: Annual and quarterly reports for (EW) to support comprehensive analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results for (EW).